ZINCOL ENTERIC COATING TABLETS

Nazione: Israele

Lingua: inglese

Fonte: Ministry of Health

Principio attivo:

ZINC AS SULFATE

Commercializzato da:

SAM-ON LTD

Codice ATC:

A12CB01

Forma farmaceutica:

TABLETS

Composizione:

ZINC AS SULFATE 50 MG

Via di somministrazione:

PER OS

Tipo di ricetta:

Required

Prodotto da:

SAM-ON LTD.,ISRAEL

Gruppo terapeutico:

ZINC SULFATE

Area terapeutica:

ZINC SULFATE

Indicazioni terapeutiche:

Zinc supplement.

Data dell'autorizzazione:

2020-05-31

Scheda tecnica

1/3
ZINCOL ENTERIC COATED TABLETS
Summary of Product Characteristics
1.
NAME OF THE MEDICINAL PRODUCT
Zincol enteric coated tablets.
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 50 mg of zinc (as sulphate) (equivalent to 137 mg
of zinc monohydrate, equivalent
to 220 mg of zinc heptahydrate).
Excipient with known effect: each tablet contains 170 mg of lactose.
For the full list of the excipients,
see section 6.1.
3.
PHARMACEUTICAL FORM
Enteric coated tablets.
4.
CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Zincol is indicated as zinc supplement.
Zinc sulphate is a source of zinc which is an essential trace element
and involved in a number of body enzyme systems.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Method of Administration: oral.
The usual dose is 1 tablet a day.
Patients should take the medicine1 hour before or 2 hours after the
meal. Patients should
wait at least 2 hours between taking
the medicine and products containing bran, foods containing copper,
iron and phosphorus such as dairy products, chicken
and turkey.
4.3 CONTRAINDICATIONS
Hypersensitivity to the active substance or any of the excipients
listed in section 6.1.
Copper deficiency (see section 4.5).
4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE
Accumulation of zinc may occur in cases of renal failure.
This product contains lactose. Patients with rare hereditary problems
of galactose intolerance, total lactase
deficiency or glucose-galactose malabsorption should not take this
medicine.
4.5 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTION
_Copper:_
Zinc may inhibit the absorption of copper (see section 4.3).
_Tetracycline Antibacterials:_
Zinc may reduce the absorption of concurrently administered
tetracyclines, also the absorption of zinc may be reduced
by tetracyclines; when both are being given an interval of at least
three hours should be allowed.
_Quinolone Antibacterials:_
Zinc may reduce the absorption of quinolones; ciprofloxacin,
levofloxacin, moxifloxacin, norfloxacin and ofloxacin.
_Calcium